Skip to main content
Erschienen in: World Journal of Pediatrics 3/2020

24.04.2020 | COVID-19 | Review article Zur Zeit gratis

Updated diagnosis, treatment and prevention of COVID-19 in children: experts’ consensus statement (condensed version of the second edition)

verfasst von: Kun-Ling Shen, Yong-Hong Yang, Rong-Meng Jiang, Tian-You Wang, Dong-Chi Zhao, Yi Jiang, Xiao-Xia Lu, Run-Ming Jin, Yue-Jie Zheng, Bao-Ping Xu, Zheng-De Xie, Zhi-sheng Liu, Xing-wang Li, Li-Kai Lin, Yun-Xiao Shang, Sai-Nan Shu, Yan Bai, Min Lu, Gen Lu, Ji-Kui Deng, Wan-Jun Luo, Li-Juan Xiong, Miao Liu, Yu-Xia Cui, Le-Ping Ye, Jia-Fu Li, Jian-Bo Shao, Li-Wei Gao, Yong-Yan Wang, Xue-Feng Wang, China National Clinical Research Center for Respiratory Diseases, National Center for Children’s Health, Beijing, China, Group of Respirology, Chinese Pediatric Society, Chinese Medical Association, Chinese Medical Doctor Association Committee on Respirology Pediatrics, China Medicine Education Association Committee on Pediatrics, Chinese Research Hospital Association Committee on Pediatrics, China Non-government Medical Institutions Association Committee on Pediatrics, China Association of Traditional Chinese Medicine, Committee on Children’s Health and Medicine Research, China News of Drug Information Association, Committee on Children’s Safety Medication, Global Pediatric Pulmonology Alliance

Erschienen in: World Journal of Pediatrics | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

In the early February, 2020, we called up an experts’ committee with more than 30 Chinese experts from 11 national medical academic organizations to formulate the first edition of consensus statement on diagnosis, treatment and prevention of coronavirus disease 2019 (COVID-19) in children, which has been published in this journal. With accumulated experiences in the diagnosis and treatment of COVID-19 in children, we have updated the consensus statement and released the second edition recently. The current version in English is a condensed version of the second edition of consensus statement on diagnosis, treatment and prevention of COVID-19 in children. In the current version, diagnosis and treatement criteria have been optimized, and early identification of severe and critical cases is highlighted. The early warning indicators for severe pediatric cases have been summarized which is utmost important for clinical practice. This version of experts consensus will be valuable for better prevention, diagnosis and treatment of COVID-19 in children worldwide.  
Literatur
6.
Zurück zum Zitat Liu Q, Wang RS, Qu GQ. General observation report on the autopsy system of death of novel coronavirus pneumonia. J Forensic Med. 2020;36:19–211 (in Chinese). Liu Q, Wang RS, Qu GQ. General observation report on the autopsy system of death of novel coronavirus pneumonia. J Forensic Med. 2020;36:19–211 (in Chinese).
7.
Zurück zum Zitat Zhang R, Li JM. The way to reduce the “false negative results” of 2019 novel coronavirus nucleic acid detection. Natl Med J China. 2020;100:E008–E00808 (in Chinese). Zhang R, Li JM. The way to reduce the “false negative results” of 2019 novel coronavirus nucleic acid detection. Natl Med J China. 2020;100:E008–E00808 (in Chinese).
8.
Zurück zum Zitat Jiang Y, Xu BP, Jin RM. Diagnosis, treatment and prevention of 2019 novel coronavirus infection in children: experts' consensus statement (First Edition). Chin J Appl Clin Pediatr. 2020;35:81–5 (in Chinese). Jiang Y, Xu BP, Jin RM. Diagnosis, treatment and prevention of 2019 novel coronavirus infection in children: experts' consensus statement (First Edition). Chin J Appl Clin Pediatr. 2020;35:81–5 (in Chinese).
9.
Zurück zum Zitat Chinese Society of Radiology. Radiological diagnosis of new coronavirus infected pneumonitis: expert recommendation from the Chinese Society of Radiology (First Edition). Chin J Radiol. 2020;54:E001. Chinese Society of Radiology. Radiological diagnosis of new coronavirus infected pneumonitis: expert recommendation from the Chinese Society of Radiology (First Edition). Chin J Radiol. 2020;54:E001.
10.
Zurück zum Zitat Ma HJ, Shao JB, Wang YJ, Zhai AG, Zheng NN, Li Q, et al. High resolution CT features of novel coronavirus pneumonia in children. Chin J Radiol. 2020;54:E002. Ma HJ, Shao JB, Wang YJ, Zhai AG, Zheng NN, Li Q, et al. High resolution CT features of novel coronavirus pneumonia in children. Chin J Radiol. 2020;54:E002.
12.
Zurück zum Zitat Chinese Medical Association Clinical Medicine Association. Expert consensus on rational drug use of aerotom inhalation therapy (2019 edition). Med Guide. 2019:135–46 (in Chinese). Chinese Medical Association Clinical Medicine Association. Expert consensus on rational drug use of aerotom inhalation therapy (2019 edition). Med Guide. 2019:135–46 (in Chinese).
15.
Zurück zum Zitat Hijano DR, Siefker DT, Shrestha B, Jaligama S, Vu LD, Tillman H, et al. Type I interferon potentiates IgA immunity to respiratory syncytial virus infection during infancy. Sci Rep. 2018;8:11034.CrossRefPubMedPubMedCentral Hijano DR, Siefker DT, Shrestha B, Jaligama S, Vu LD, Tillman H, et al. Type I interferon potentiates IgA immunity to respiratory syncytial virus infection during infancy. Sci Rep. 2018;8:11034.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Al-Tawfiq JA, Momattin H, Dib J, Memish ZA. Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study. Int J Infect Dis. 2014;20:42–6.CrossRefPubMedPubMedCentral Al-Tawfiq JA, Momattin H, Dib J, Memish ZA. Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study. Int J Infect Dis. 2014;20:42–6.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Wang HQ, Ma LL, Jiang JD, Pang R, Chen YJ, Li YH. Recombinant human interferon alpha 2b broad-spectrum anti-respiratory viruses pharmacodynamics study in vitro. Acta Pharm Sin. 2014;49:1547–53. Wang HQ, Ma LL, Jiang JD, Pang R, Chen YJ, Li YH. Recombinant human interferon alpha 2b broad-spectrum anti-respiratory viruses pharmacodynamics study in vitro. Acta Pharm Sin. 2014;49:1547–53.
18.
Zurück zum Zitat Liu B, Shang YX, Lu YD. Safety of aerosol inhalation of recombinant human interferon α2b injection (P. putida) and excipient hydroxyethyl starch 40 to healthy SD rats. Int J Pediatr. 2019;46:692–7. Liu B, Shang YX, Lu YD. Safety of aerosol inhalation of recombinant human interferon α2b injection (P. putida) and excipient hydroxyethyl starch 40 to healthy SD rats. Int J Pediatr. 2019;46:692–7.
20.
Zurück zum Zitat The Subspecialty Group of Infectious Diseases, the Society of Pediatrics, Chinese Medical Association; National Center for Quality Control of Infectious Diseases. Expert consensus on diagnosis and treatment of herpangina (version 2019). Chin J Pediatr. 2019;57:177–80. The Subspecialty Group of Infectious Diseases, the Society of Pediatrics, Chinese Medical Association; National Center for Quality Control of Infectious Diseases. Expert consensus on diagnosis and treatment of herpangina (version 2019). Chin J Pediatr. 2019;57:177–80.
21.
Zurück zum Zitat Shen KL, Shang YX, Zhang H, Liu CH, Yang QZ, Chen YJ, et al. A multicenter randomized controlled clinical study on the efficacy and safety of recombinant human interferon α2b spray (P. putida) in treatment of acute upper respiratory tract infections in children. Chin J Pract Pediatr. 2019;34:1010–6. Shen KL, Shang YX, Zhang H, Liu CH, Yang QZ, Chen YJ, et al. A multicenter randomized controlled clinical study on the efficacy and safety of recombinant human interferon α2b spray (P. putida) in treatment of acute upper respiratory tract infections in children. Chin J Pract Pediatr. 2019;34:1010–6.
22.
Zurück zum Zitat Shen KL, Shang YX, Zhang GC. Expert consensus on the rational application of interferon alpha in pediatrics. Chin J Appl Clin Pediatr. 2018;33:1301–8. Shen KL, Shang YX, Zhang GC. Expert consensus on the rational application of interferon alpha in pediatrics. Chin J Appl Clin Pediatr. 2018;33:1301–8.
23.
Zurück zum Zitat The Expert Committee on Pediatric Medicine of National Health and Commission, National Health and Family Planning Commission of The People’s Republic of China; Respiratory Group, Pediatric Section of Chinese Medical Association; Committee of Respiratory Disease, Pediatric Society of Chinese Physicians’ Association, et al. Guidelines for rational drug use in children with wheezing disorders. Chin J Appl Clin Pediatr. 2018;33:1460–72. The Expert Committee on Pediatric Medicine of National Health and Commission, National Health and Family Planning Commission of The People’s Republic of China; Respiratory Group, Pediatric Section of Chinese Medical Association; Committee of Respiratory Disease, Pediatric Society of Chinese Physicians’ Association, et al. Guidelines for rational drug use in children with wheezing disorders. Chin J Appl Clin Pediatr. 2018;33:1460–72.
27.
Zurück zum Zitat Endoscopy Committee, Pediatric Section of Chinese Medical Doctor Association;Pediatric Respiratory Endoscopy Committee, Endoscopists Section of Chinese Medical Doctor Association; Bronchoscopy Collaboration Subgroup of Respirology Group, Pediatric Section of Chinese Medical Association, et al. Recommendations on the pediatric flexible bronchoscopy during the outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in China (Trial Edition). Chin J Appl Clin Pediatr. 2020;35:92–6. Endoscopy Committee, Pediatric Section of Chinese Medical Doctor Association;Pediatric Respiratory Endoscopy Committee, Endoscopists Section of Chinese Medical Doctor Association; Bronchoscopy Collaboration Subgroup of Respirology Group, Pediatric Section of Chinese Medical Association, et al. Recommendations on the pediatric flexible bronchoscopy during the outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in China (Trial Edition). Chin J Appl Clin Pediatr. 2020;35:92–6.
Metadaten
Titel
Updated diagnosis, treatment and prevention of COVID-19 in children: experts’ consensus statement (condensed version of the second edition)
verfasst von
Kun-Ling Shen
Yong-Hong Yang
Rong-Meng Jiang
Tian-You Wang
Dong-Chi Zhao
Yi Jiang
Xiao-Xia Lu
Run-Ming Jin
Yue-Jie Zheng
Bao-Ping Xu
Zheng-De Xie
Zhi-sheng Liu
Xing-wang Li
Li-Kai Lin
Yun-Xiao Shang
Sai-Nan Shu
Yan Bai
Min Lu
Gen Lu
Ji-Kui Deng
Wan-Jun Luo
Li-Juan Xiong
Miao Liu
Yu-Xia Cui
Le-Ping Ye
Jia-Fu Li
Jian-Bo Shao
Li-Wei Gao
Yong-Yan Wang
Xue-Feng Wang
China National Clinical Research Center for Respiratory Diseases
National Center for Children’s Health, Beijing, China
Group of Respirology, Chinese Pediatric Society, Chinese Medical Association
Chinese Medical Doctor Association Committee on Respirology Pediatrics
China Medicine Education Association Committee on Pediatrics
Chinese Research Hospital Association Committee on Pediatrics
China Non-government Medical Institutions Association Committee on Pediatrics
China Association of Traditional Chinese Medicine, Committee on Children’s Health and Medicine Research
China News of Drug Information Association, Committee on Children’s Safety Medication
Global Pediatric Pulmonology Alliance
Publikationsdatum
24.04.2020

Weitere Artikel der Ausgabe 3/2020

World Journal of Pediatrics 3/2020 Zur Ausgabe

Das könnte Sie auch interessieren

21.04.2020 | Pädiatrie | Übersichten Zur Zeit gratis

So verläuft COVID-19 bei Kindern und Jugendlichen

Ein systematischer Review zu publizierten Fallserien (Stand 31.03.2020) und erste Daten aus Deutschland

Passend zum Thema

ANZEIGE

IPD-Fallzahlen & Pneumokokken-Impfung bei Kindern in Deutschland

Das Niveau der postpandemischen Fallzahlen für invasive Pneumokokken-Erkrankungen (IPD) ist aus Sicht des Referenz-Zentrums für Streptokokken in Aachen alarmierend [1]. Wie sich die monatlichen IPD-Fallzahlen bei Kindern und Jugendlichen von Juli 2015 bis März 2023 entwickelt haben, lesen Sie hier.

ANZEIGE

HPV-Impfung: Auch für junge Erwachsene sinnvoll und wichtig

Auch nach dem 18. Lebensjahr kann eine HPV-Impfung sinnvoll und wichtig sein. Viele gesetzliche Krankenkassen übernehmen die Kosten auch zu einem späteren Zeitpunkt noch.

ANZEIGE

Impfstoffe – Krankheiten vorbeugen, bevor sie entstehen

Seit mehr als 130 Jahren entwickelt und produziert MSD Impfstoffe für alle Altersgruppen. Hier finden Sie nützliche Informationen und Praxismaterialien rund um das Thema Impfen.

MSD Sharp & Dohme GmbH

Passend zum Thema

ANZEIGE
OnSite Advertorial Anaphylaxie
Anaphylaxie

Es wäre so einfach, ein Leben zu retten – Wenn man nur daran denkt…

Anaphylaxie ist eine akute schwere allergische Reaktion und somit die schwerste Komplikation in der Allergologie. Darauf sollten Ärztinnen und Ärzte vorbereitet sein.